Mary’s Medicinals, exclusive producer and distributor of transdermal cannabis patches, gels and compounds, has an esteemed line of Terpene Enriched cannabinoid supplements including the first products to feature isolated CBN.

Cannabinol (CBN) is an effective anti-epileptic, anti-spasmodic and reliever of intra-ocular pressure. Recent studies suggest that CBN can be administered as an antidepressant, to prevent convulsions and to sedate patients experiencing pain. It is ideal for those suffering from Glaucoma, inflammation and insomnia.

To meet the growing demand for reliably dosed, smokeless, non-psychoactive marijuana consumption options, Mary’s is expanding its line of nutraceutical products to include capsules that complement its transdermal patches, compounds and gels.

About Mary’s Medicinals: Mary’s Medicinals is a nutraceutical company innovating at the intersection of engineering and horticulture. Mary’s is focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care. More information is availableat: http://www.marysmedicinals.com/